Target intelligence / Profile preview

Cancer cell invasion

Molecular classification
Other (not a molecule, but a cellular process)
01

Overview

Cancer cell invasion refers to the process by which malignant cells penetrate surrounding tissue barriers to enable local or distant spread (metastasis). It is a hallmark of cancer progression and involves changes in cell motility, adhesion, cytoskeletal dynamics, proteolytic degradation of the extracellular matrix (primarily mediated by matrix metalloproteinases and related enzymes), and signaling alterations such as those driven by epithelial-mesenchymal transition (EMT). Central molecules in invasion include integrins, actin cytoskeleton modulators (such as Rac1, Cdc42), and proteases (notably MMPs). Cancer cell invasion may occur via multiple patterns, including collective or individual cell migration[1][2][3][4][5]. Summary: "Cancer cell invasion" is not a molecular target, but a process involving multiple molecules (e.g., integrins, MMPs, actin regulators). For studies of drug mechanisms, specific molecular effectors (e.g., "matrix metalloproteinase-9", "integrin β1", "epidermal growth factor receptor") should be specified, as they are valid molecular targets within the invasion process.

Other names
Tumor cell invasionNeoplastic invasionMalignant cell invasionInvasive behavior
02

Biological functions

Cell migrationExtracellular matrix remodelingEpithelial-mesenchymal transitionSignal transductionCell adhesionProteolysis
03

Disease associations

Cancer
04

Biomarkers

Circulating fragments of E-cadherin (from MMP7 cleavage) have been proposed as potential biomarkers for monitoring cancer cell invasion in patients[1]Matrix metalloproteinase (MMP) expression/activity, particularly MMP2, MMP7, MMP9[1][3][4]EMT markers (e.g., Snail, Slug)[1]

Beyond the preview

Go deeper on Cancer cell invasion.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cancer cell invasion.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call